"[Pharma] is always a little bit behind when it comes to using the latest and greatest because we are such a heavily regulated industry, and that makes a lot of sense—we have to be conservative. But we're starting to get to the point where cloud computing is really becoming the norm."
The quote above taken from this online article:
...
Benchmark prices are important in many in many industries. They can set the basis for reimbursement, provide a reference to discounts offered and can provide part of the basis for product comparison. In the US pharmaceutical industry, one often used benchmark price has been the Average Wholesale Price (AWP). In particular, AWP has been used frequently as the basis for State reimbursement to...
For those of us out in the West Coast, October usually brings the first precipitation of the rainy season. It also means that RAINMAKER, the annual industry gathering of Life Sciences and High Tech Revenue Management practitioners, is right around the corner.
RAINMAKER 2012 moves ever so slightly down the coast to the elegant Hotel del Coronado outside San Diego, March 6-8.Building on...
Model N is sponsoring the annual Global Semiconductor Alliance Awards Dinner in Santa Clara, CA on December 8. Founder and CEO Zack Rinat (left) will present one of the night's awards. More info...
On November 8 and 9 Model N sponsored the first-annual European Pricing Platform (ePP) High Tech PricingFuel Day in London.
The two-day event drew pricing practitioners from across Europe and across a range of High Tech manufacturing sectors, including semiconductors, electronic components, consumer electronics OEMs, and telco.
iSuppli VP Eric Pratt gave the keynote, which...
Interesting (if not slightly pessimistic) prediction of the next few years in biopharma from Roche head over at Fierce (http://www.fiercepharma.com/story/roche-chief-warns-perfect-pharma-storm...)....
HHS head Kathleen Sebelius announced (or dumped) on Friday the news that the White House was backing away from imposing highly specific minimum benefit requirements for private insurers on the health exchanges and allowing states much more leeway within broad categories. While this was likely a political decision resulting from criticism that HCR was too top-down in its approach, it will have...
Interesting look (http://www.nytimes.com/2012/01/22/business/apple-america-and-a-squeezed-...) at some of the...
With SCOTUS preparing to take a vote on the individual mandate of the Affordable Care Act (ACA), there is much speculation over what will happen. Many court observers were surprised by the lines of questioning taken by the conservative wing of the court and now have doubts regarding the mandate’s (or the entire bill’s) survival.
There are a...